Dipharma Francis S.r.l. (Dipharma), a CDMO and global producer of APIs, announced that their manufacturing facility situated in Caronno Pertusella, near Milan, Italy, has been awarded the Good Manufacturing Practice (GMP) certification - CBPF (Certificado de Boas Práticas de Fabricação) - by the Regulatory Authority of Brazil, ANVISA (Agência Nacional de Vigilância Sanitária).
This endorsement complements the prior certification obtained in November 2022 for Dipharma's Italian site in Baranzate (Milan), affirming the exceptional quality system upheld by Dipharma, a recognition widely acknowledged by regulatory bodies. The Caronno Pertusella facility has undergone consistent and successful inspections by both the US FDA and the Italian Ministry of Health (AIFA) for over five decades.
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special
offers from Pharmaceutical Outsourcing – all delivered right to your inbox! Sign up now!